Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients
NCT ID: NCT06897436
Last Updated: 2025-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
60 participants
OBSERVATIONAL
2025-05-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
NCT01301885
Superficial and Deep Endometriosis: Role of Systemic Inflammation as a Marker of Clinical, Surgical, and Reproductive Outcomes
NCT06470594
The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometriosis
NCT05788952
Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care
NCT06331676
Endometriosis and Chronic Endometritis
NCT05824507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
pre-menopausal adult women with clinically and/or ultrasound-diagnosed endometriosis, age between 18 and 40 years, with regular menstruation, without autoimmune diseases, without malignant diseases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 50 years
* Pre-menopausal status
* Experiencing regular menstruation
* Willing to collect menstrual effluent
* Signature of informed consent to the study
Exclusion Criteria
* Post-Menopausal status
* Presence of Crohn's disease
* Presence of Ulcerative Colitis
* Presence of short bowel syndrome or another chronic inflammatory disease
* Use immunosuppressive medication
* Receiving contraceptive hormone therapy
* Pregnant
* Presence/history of malignancy
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Commission
OTHER
Medical University of Lublin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iwona Wertel
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jarogniew Ćuszczki, professor
Role: STUDY_DIRECTOR
UNIWERSYTET MEDYCZNY W LUBLINIE
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
CORDIS belongs to the Research and Innovation community platform of the European Commission and complements the Funding and tender opportunities website, where there is possibility to apply for funding and search for partners.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Project 101157146-EUmetriosis
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
101157146
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.